Rubin, K.; Ewing, P.; Bäckström, E.; Abrahamsson, A.; Bonn, B.; Kamata, S.; Grime, K.
Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model. Pharmaceutics 2020, 12, 117.
https://doi.org/10.3390/pharmaceutics12020117
AMA Style
Rubin K, Ewing P, Bäckström E, Abrahamsson A, Bonn B, Kamata S, Grime K.
Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model. Pharmaceutics. 2020; 12(2):117.
https://doi.org/10.3390/pharmaceutics12020117
Chicago/Turabian Style
Rubin, Katarina, Pär Ewing, Erica Bäckström, Anna Abrahamsson, Britta Bonn, Satoshi Kamata, and Ken Grime.
2020. "Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model" Pharmaceutics 12, no. 2: 117.
https://doi.org/10.3390/pharmaceutics12020117
APA Style
Rubin, K., Ewing, P., Bäckström, E., Abrahamsson, A., Bonn, B., Kamata, S., & Grime, K.
(2020). Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model. Pharmaceutics, 12(2), 117.
https://doi.org/10.3390/pharmaceutics12020117
